Holger Sellner
Novartis (China)(CN)
Publications by Year
Research Areas
Immune cells in cancer, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Hippo pathway signaling and YAP/TAZ, Chemical Synthesis and Analysis, Dendrimers and Hyperbranched Polymers
Most-Cited Works
- → Small-molecule factor B inhibitor for the treatment of complement-mediated diseases(2019)210 cited
- → Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers(2024)114 cited
- → Dendritically Cross-Linking Chiral Ligands: High Stability of a Polystyrene-Bound Ti-TADDOLate Catalyst with Diffusion Control(1999)113 cited
- → Immobilization of BINOL by Cross-Linking Copolymerization of Styryl Derivatives with Styrene, and Applications in Enantioselective Ti and Al Lewis Acid Mediated Additions of Et2Zn and Me3SiCN to Aldehydes and of Diphenyl Nitrone to Enol Ethers(2000)112 cited
- → Chiral Dendrimers(1998)99 cited
- → Preparation of Dendritic and Non-Dendritic Styryl-Substituted Salens for Cross-Linking Suspension Copolymerization with Styrene and Multiple Use of the Corresponding Mn and Cr Complexes in Enantioselective Epoxidations and Hetero-Diels–Alder Reactions(2001)96 cited
- → Dendritic styryl TADDOLs as novel polymer cross‐linkers: First application in an enantioselective Et2Zn addition mediated by a polymer‐incorporated titanate. Preliminary communication(1997)94 cited
- → Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer(2021)69 cited
- → Preparation of Polystyrene Beads with Dendritically Embedded TADDOL and Use in EnantioselectiveLewis Acid Catalysis(2002)65 cited
- → Discovery of 4-((2 S ,4 S )-4-Ethoxy-1-((5-methoxy-7-methyl-1 H -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases(2020)59 cited